Physician profile
Brian Gluck
NPI 1912972456
$4,675.13
in general payments reported to CMS, 2019-2025
17 companies · $525 in 2025
The $525 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,844 · 2020: $162 · 2021: $533 · 2022: $782 · 2023: $614 · 2024: $215 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,270 · Education: $83.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,269.77 |
| Education | $83.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,366.29 | 2019-2023 | |
| Medtronic, INC. | $1,340.87 | 2021-2025 | Signia, Sonicision |
| Ethicon US, LLC | $452.25 | 2019-2025 | Vistaseal, Stratafix, Echelon Endopath |
| W. L. Gore & Associates, INC. | $377.49 | 2019-2023 | Seamguard |
| Novo Nordisk INC | $260.35 | 2019-2025 | Wegovy, Saxenda |
| Heron Therapeutics, INC. | $219.29 | 2025 | Zynrelef |
| Covidien Lp | $155.98 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $111.01 | 2019 | |
| Baxter Healthcare | $105.66 | 2021-2023 | Tisseel |
| Astrazeneca Pharmaceuticals Lp | $68.49 | 2025 | Imfinzi |
| Lilly USA, LLC | $46.35 | 2024 | Zepbound |
| Olympus America INC. | $32.27 | 2023 | Endoeye Flex Deflectable Videoscope, Olympus |
| Takeda Pharmaceuticals U.S.A., INC. | $30.44 | 2022-2023 | Gattex |
| Redhill Biopharma INC. | $29.85 | 2021 | |
| Integra Lifesciences Corporation | $29.15 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $26.08 | 2023 | Da Vinci Surgical System |
| Phathom Pharmaceuticals, INC. | $23.31 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Gluck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.